MSD has reported positive topline outcomes from the Phase III MK-3475A-D77 study assessing the noninferiority of subcutaneous ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently ...

The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

Additional doses of 1.25 mg may be given at six-hour intervals. For patients with a creatinine clearance of ≤30 mL/min (serum creatinine concentration of ≥3 mg/dL), the starting dose should be ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

Purpose. Intravenous antihypertensive agents for the treatment of hypertensive emergencies are reviewed. Summary. An estimated 500,000 people in the United States experience a hypertensive crisis ...

Every Friday, we will be highlighting a local business in South Dakota. This week, Black Hills Insider visited Hydration ...

The health district's needle exchange program is doing its job and reducing harm, officials told the Yakima City Council.

60.3% of participants self-identified as white adults, 27.9% as Black adults, 10.3% as Asian adults and 1.5% self-identified as adults of "other" race. 32.4% identified as Hispanic or Latino ethnicity ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Merck (MRK) announced positive topline results from the pivotal Phase 3 MK-3475A-D77 trial. The trial is evaluating the noninferiority of ...